Muhammad Rajaei Ahmad Mohd Zain
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Muhammad Rajaei Ahmad Mohd Zain has a total of 89 co-authors. Here are the top co-authors by number of shared publications:
- Hisham Atan Edinur
School of Health Sciences, Health Campus, Universiti Sains Malaysia, Kubang Kerian, Malaysia
5 shared publications Zulhisyam Abdul Kari
Department of Agriculture Science, Faculty of Agro-Based Industry, Universiti Malaysia Kelantan
5 shared publicationsArifullah Mohammed
Department of Biotechnology, Koneru Lakshmaiah University (KLEF)
4 shared publicationsSiddhartha Pati
Department of Biotechnology, MaulanaAbulKalam Azad University of Technology, Kolkata, West Bengal, India
4 shared publications- Asma Abdullah Nurul
School of Health Sciences, Universiti Sains Malaysia, Kelantan, Malaysia
3 shared publications Dibyajit Lahiri
Department of Biotechnology, MaulanaAbulKalam Azad University of Technology, Kolkata, West Bengal, India
3 shared publications
Latest Publications
- Open Access
- 13 November 2026
- Published by EDP Sciences in SICOT-J
- Vol. 12, 83
Biofilms in drug-coated medical devices: Mechanisms of antimicrobial resistance and perspectives on new approaches
Background : Bacterial biofilms are a major cause of treatment failure in orthopedic implant surgery, contributing to a large proportion of chronic, device-associated infections. Biofilms contain bacteria that are able to survive antimicrobial concentrations 10–1,000-fold higher than the planktonic equivalent, and antimicrobial-coated implants, which are designed to limit this risk, can still be colonized after depletion of the antimicrobial reservoir on the implant. This systematic review aims to address how biofilm-associated antimicrobial resistance occurs on drug-coated orthopedic devices and what current and future strategies can be employed to prevent it. Methods : During the preparation of this manuscript, a literature base of 72 references was identified and screened for direct or translatable relevance to orthopedic implants and musculoskeletal device-associated infection, using explicit criteria. Eligible studies focused on mechanisms of biofilm formation or antimicrobial resistance or on the efficacy of device technology designed to inhibit fouling or disrupt biofilms or incorporate drugs. Non-orthopedic devices (urinary, cardiovascular, dental) were included only where they provided an example of a mechanism or coating that had a reasonable chance for translation to orthopedics and are marked as such throughout. Results : The formation of a biofilm on orthopedic implant surfaces occurs in five broadly accepted stages: reversible attachment, irreversible adhesion, formation of microcolonies, maturation, and dispersal, with most of the orchestration of these stages being regulated by quorum-sensing signaling. The resistance of mature biofilm is due to multiple overlapping mechanisms, including the limitation of matrix diffusion, oxygen and metabolic gradients that stimulate the growth of persister cells, upregulation of efflux pumps, enzymatic degradation of drugs, and increased horizontal gene transfer. In a pooled analysis of seven comparative studies, current drug-coated orthopedic devices (e.g., gentamicin- or silver-coated tibial nails and arthroplasty components) have been found to have a lower periprosthetic infection rate than uncoated devices (2.93, 95% CI 1.72–4.99, p < 0.001). Antifouling (PEG-based) surface modifications, enzymatic matrix-disrupting agents, bacteriophage-based therapies and biosensor-triggered smart implants are consistently effective in vitro and in pre-clinical models, although only limited clinical-trial evidence has been generated for most of these approaches related to orthopedic implants. Conclusions : The scientific basis for biofilm-related resistance mechanisms is solid and heterogeneous: the quantitative efficacy claims of next-generation coatings have been supported by in vitro or preclinical studies, but not by orthopedic clinical studies. Future clinical trials in the field would focus on novel clinical evaluation of antifouling and enzymatic methods for preventing prosthetic joint infections, standardized reporting of biofilm results, and the risk-stratified use of antimicrobial coatings to reduce unnecessary antimicrobial exposure.
- 13 November 2026
- Published by EDP Sciences in SICOT-J
- Vol. 12, 83
Open AccessBiofilms in drug-coated medical devices: Mechanisms of antimicrobial resistance and perspectives on new approaches
Background : Bacterial biofilms are a major cause of treatment failure in orthopedic implant surgery, contributing to a large proportion of chronic, device-associated infections. Biofilms contain bacteria that are able to survive antimicrobial concentrations 10–1,000-fold higher than the planktonic equivalent, and antimicrobial-coated implants, which are designed to limit this risk, can still be colonized after depletion of the antimicrobial reservoir on the implant. This systematic review aims to address how biofilm-associated antimicrobial resistance occurs on drug-coated orthopedic devices and what current and future strategies can be employed to prevent it. Methods : During the preparation of this manuscript, a literature base of 72 references was identified and screened for direct or translatable relevance to orthopedic implants and musculoskeletal device-associated infection, using explicit criteria. Eligible studies focused on mechanisms of biofilm formation or antimicrobial resistance or on the efficacy of device technology designed to inhibit fouling or disrupt biofilms or incorporate drugs. Non-orthopedic devices (urinary, cardiovascular, dental) were included only where they provided an example of a mechanism or coating that had a reasonable chance for translation to orthopedics and are marked as such throughout. Results : The formation of a biofilm on orthopedic implant surfaces occurs in five broadly accepted stages: reversible attachment, irreversible adhesion, formation of microcolonies, maturation, and dispersal, with most of the orchestration of these stages being regulated by quorum-sensing signaling. The resistance of mature biofilm is due to multiple overlapping mechanisms, including the limitation of matrix diffusion, oxygen and metabolic gradients that stimulate the growth of persister cells, upregulation of efflux pumps, enzymatic degradation of drugs, and increased horizontal gene transfer. In a pooled analysis of seven comparative studies, current drug-coated orthopedic devices (e.g., gentamicin- or silver-coated tibial nails and arthroplasty components) have been found to have a lower periprosthetic infection rate than uncoated devices (2.93, 95% CI 1.72–4.99, p < 0.001). Antifouling (PEG-based) surface modifications, enzymatic matrix-disrupting agents, bacteriophage-based therapies and biosensor-triggered smart implants are consistently effective in vitro and in pre-clinical models, although only limited clinical-trial evidence has been generated for most of these approaches related to orthopedic implants. Conclusions : The scientific basis for biofilm-related resistance mechanisms is solid and heterogeneous: the quantitative efficacy claims of next-generation coatings have been supported by in vitro or preclinical studies, but not by orthopedic clinical studies. Future clinical trials in the field would focus on novel clinical evaluation of antifouling and enzymatic methods for preventing prosthetic joint infections, standardized reporting of biofilm results, and the risk-stratified use of antimicrobial coatings to reduce unnecessary antimicrobial exposure.
- Open Access
- 1 January 2026
- Published by Tech Science Press in Oncology Research
- Vol. 34 (4) , 1-10
Efficacy and Mechanisms of CDK4/6 Inhibitors in Breast Cancer: Advancing Targeted Therapeutic Strategies
Breast cancer remains the primary cause of cancer-related mortality for women globally; therefore, further breakthroughs in treatment approaches are crucial. Palbociclib, ribociclib, and abemaciclib are among the Cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors that have become an innovative family of targeted therapy for hormone receptor-positive, Human Epidermal Growth factor receptor 2 (HR+/HER2−) breast cancer. These inhibitors work by preventing the action of CDK4/6, which are crucial in the regulation of the cell cycle. Leading cancer cells to cell cycle arrest and undergo apoptosis. When these inhibitors are used with endocrine medicines like letrozole and fulvestrant, clinical trials lead positive impact in progression-free survival and, in a few cases, complete survival. However, despite their effectiveness, resistance mechanisms are primary and current acquired problems, requiring combined approaches with additional targeted medicines and continuous investigation into innovative therapeutic plans. To maintain patient compliance and quality of life, common side effects such as tiredness, gastrointestinal problems, and neutropenia need to be effectively managed. There is hopefulness for wider oncological applications as next-generation CDK inhibitor development and adaptive clinical trials continue to test their potential beyond breast cancer. CDK4/6 inhibitors continue to be a key part of breast cancer treatment as cancer biology advances, marking a major advancement towards more potent and customized cancer medicines. This review aims to provide current evidence on CDK4/6 inhibitors in HR+/HER2− breast cancer, highlighting their mechanisms, interaction with endocrine resistance, combination strategies, and emerging biomarkers guiding personalized therapy.
- 1 January 2026
- Published by Tech Science Press in Oncology Research
- Vol. 34 (4) , 1-10
Open AccessEfficacy and Mechanisms of CDK4/6 Inhibitors in Breast Cancer: Advancing Targeted Therapeutic Strategies
Breast cancer remains the primary cause of cancer-related mortality for women globally; therefore, further breakthroughs in treatment approaches are crucial. Palbociclib, ribociclib, and abemaciclib are among the Cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors that have become an innovative family of targeted therapy for hormone receptor-positive, Human Epidermal Growth factor receptor 2 (HR+/HER2−) breast cancer. These inhibitors work by preventing the action of CDK4/6, which are crucial in the regulation of the cell cycle. Leading cancer cells to cell cycle arrest and undergo apoptosis. When these inhibitors are used with endocrine medicines like letrozole and fulvestrant, clinical trials lead positive impact in progression-free survival and, in a few cases, complete survival. However, despite their effectiveness, resistance mechanisms are primary and current acquired problems, requiring combined approaches with additional targeted medicines and continuous investigation into innovative therapeutic plans. To maintain patient compliance and quality of life, common side effects such as tiredness, gastrointestinal problems, and neutropenia need to be effectively managed. There is hopefulness for wider oncological applications as next-generation CDK inhibitor development and adaptive clinical trials continue to test their potential beyond breast cancer. CDK4/6 inhibitors continue to be a key part of breast cancer treatment as cancer biology advances, marking a major advancement towards more potent and customized cancer medicines. This review aims to provide current evidence on CDK4/6 inhibitors in HR+/HER2− breast cancer, highlighting their mechanisms, interaction with endocrine resistance, combination strategies, and emerging biomarkers guiding personalized therapy.
- Open Access
- 25 July 2025
- Published by Bangladesh Academy of Sciences in Bangladesh Journal of Medical Science
- Vol. 24 (3) , 746-763
The Global Research Landscape of Knee Osteoarthritis Pain Management: A Bibliometric Analysis
Background Knee osteoarthritis (OA) is a significant public health concern among the elderly due to the global aging population. It is a widespread and crippling type of joint ailment that results in pain and immobility for millions around the globe. Nonetheless, even with such treatments like medications and physical therapy, effective pain management remains a significant challenge. This study aimed to measure the quantitative impact of publications in knee OA and its pain management. Materials and methods Article titles from the Scopus database were screened as of March 31, 2024, utilizing keywords related to knee OA and pain management or conservative therapy. The documents underwent frequency analysis using Microsoft Excel, data visualization employing VOSviewer, and citation metrics analysis using Harzing’s Publish or Perish software. Results and discussion A total of 1087 documents analyzed revealed a consistent upward trajectory in the number of publications focused on knee OA and pain management strategies since 1975 until March 2024. The United States of America (USA) ranked first as the leading contributor to research activity in this field. The analysis encompassed contributions from 160 scholars representing 77 countries and 160 institutions. The publications spanned articles in multiple languages and involved multiple authors. In terms of publication numbers, the top three institutions were the University of Sydney, the University of Melbourne, and Harvard Medical School. Conclusion This study provides a comprehensive bibliometric overview of the published literature on pain management strategies for knee OA patients over the past five decades. The findings underscore the need for future research efforts to prioritize the exploration of novel pain management approaches for individuals with knee OA, as well as elucidate the underlying mechanisms contributing to pain manifestation in this patient population. Continued interdisciplinary collaboration and knowledge dissemination will be crucial in advancing our understanding and management of knee OA-related pain. BJMS, Vol. 24 No. 03 July’25 Page : 746-763
- 25 July 2025
- Published by Bangladesh Academy of Sciences in Bangladesh Journal of Medical Science
- Vol. 24 (3) , 746-763
Open AccessThe Global Research Landscape of Knee Osteoarthritis Pain Management: A Bibliometric Analysis
Background Knee osteoarthritis (OA) is a significant public health concern among the elderly due to the global aging population. It is a widespread and crippling type of joint ailment that results in pain and immobility for millions around the globe. Nonetheless, even with such treatments like medications and physical therapy, effective pain management remains a significant challenge. This study aimed to measure the quantitative impact of publications in knee OA and its pain management. Materials and methods Article titles from the Scopus database were screened as of March 31, 2024, utilizing keywords related to knee OA and pain management or conservative therapy. The documents underwent frequency analysis using Microsoft Excel, data visualization employing VOSviewer, and citation metrics analysis using Harzing’s Publish or Perish software. Results and discussion A total of 1087 documents analyzed revealed a consistent upward trajectory in the number of publications focused on knee OA and pain management strategies since 1975 until March 2024. The United States of America (USA) ranked first as the leading contributor to research activity in this field. The analysis encompassed contributions from 160 scholars representing 77 countries and 160 institutions. The publications spanned articles in multiple languages and involved multiple authors. In terms of publication numbers, the top three institutions were the University of Sydney, the University of Melbourne, and Harvard Medical School. Conclusion This study provides a comprehensive bibliometric overview of the published literature on pain management strategies for knee OA patients over the past five decades. The findings underscore the need for future research efforts to prioritize the exploration of novel pain management approaches for individuals with knee OA, as well as elucidate the underlying mechanisms contributing to pain manifestation in this patient population. Continued interdisciplinary collaboration and knowledge dissemination will be crucial in advancing our understanding and management of knee OA-related pain. BJMS, Vol. 24 No. 03 July’25 Page : 746-763
- 19 December 2024
- Published by Taylor & Francis in Immunological Investigations
- Vol. 54 (3) , 352-367
Synovial Fluid-Derived Exosomes from Osteoarthritis Patients Modulate Cell Surface Phenotypes of Monocytes and Cytokine Secretions
Exosomes can be found in the synovial fluid of inflamed knee joints, which play a significant role in osteoarthritis (OA) progression. However, their role - in modulating the cellular environment within the body, particularly monocytes remain unexplored. This study aimed to evaluate the immunomodulatory effect of exosomes on monocytes. Exosomes were isolated by ultracentrifugation and characterized using nanoparticle tracking analysis (NTA), scanning electron microscopy (SEM), and Western blot. The effect of exosomes in modulating monocyte phenotypes as well as cytokine secretion were further assessed in a co-culture condition using flow cytometry and ELISA accordingly. Exosomes were identified as spherical particles with a size distribution ranging from 30 nm to 150 nm. These nanoparticles intensely expressed exosome protein markers including CD9, CD63, CD81, and HSP70. The expression of HLA-DR, CD14, and CD11b on monocytes decreased in the presence of exosomes after 24 h of incubation, regardless of the dose. Exosomes significantly induced the release of anti-inflammatory cytokines IL-1Ra in a time- and dose-dependent manner, while TNF-α secretion remains unchanged regardless of the presence or absence of exosomes. This study highlights the immunoregulatory role of exosomes on monocytes, emphasizing the need for further studies into the underlying mechanism.
- 19 December 2024
- Published by Taylor & Francis in Immunological Investigations
- Vol. 54 (3) , 352-367
Synovial Fluid-Derived Exosomes from Osteoarthritis Patients Modulate Cell Surface Phenotypes of Monocytes and Cytokine Secretions
Exosomes can be found in the synovial fluid of inflamed knee joints, which play a significant role in osteoarthritis (OA) progression. However, their role - in modulating the cellular environment within the body, particularly monocytes remain unexplored. This study aimed to evaluate the immunomodulatory effect of exosomes on monocytes. Exosomes were isolated by ultracentrifugation and characterized using nanoparticle tracking analysis (NTA), scanning electron microscopy (SEM), and Western blot. The effect of exosomes in modulating monocyte phenotypes as well as cytokine secretion were further assessed in a co-culture condition using flow cytometry and ELISA accordingly. Exosomes were identified as spherical particles with a size distribution ranging from 30 nm to 150 nm. These nanoparticles intensely expressed exosome protein markers including CD9, CD63, CD81, and HSP70. The expression of HLA-DR, CD14, and CD11b on monocytes decreased in the presence of exosomes after 24 h of incubation, regardless of the dose. Exosomes significantly induced the release of anti-inflammatory cytokines IL-1Ra in a time- and dose-dependent manner, while TNF-α secretion remains unchanged regardless of the presence or absence of exosomes. This study highlights the immunoregulatory role of exosomes on monocytes, emphasizing the need for further studies into the underlying mechanism.
- Open Access
- 7 March 2023
- Published by Frontiers Media SA in Frontiers in Chemistry
- Vol. 11, 1118454
Biogenic silver nanoparticles (AgNPs) from Tinosporacordifolia leaves: An effective antibiofilm agent against Staphylococcus aureus ATCC 23235
Medicinal plants are long known for their therapeutic applications. Tinospora cordifolia (commonly called gulancha or heart-leaved moonseed plant), a herbaceous creeper widely has been found to have antimicrobial, anti-inflammatory, anti-diabetic, and anti-cancer properties. However, there remains a dearth of reports regarding its antibiofilm activities. In the present study, the anti-biofilm activities of phytoextractof T. cordifolia and the silver nanoparticles made from this phytoextract were tested against the biofilm of S.taphylococcus aureus, one of the major nosocomial infection-producing bacteria taking tetracycline antibiotic as control. Both phytoextract from the leaves of T. cordifolia, and the biogenic AgNPs from the leaf extract of T. cordifolia, were found successful in reducing the biofilm of Staphylococcus aureus. The biogenic AgNPs formed were characterized by UV- Vis spectroscopy, Field emission Scanning Electron Microscopy (FE- SEM), and Dynamic light scattering (DLS) technique. FE- SEM images showed that the AgNPs were of size ranging between 30 and 50 nm and were stable in nature, as depicted by the zeta potential analyzer. MIC values for phytoextract and AgNPs were found to be 180 mg/mL and 150 μg/mL against S. aureusrespectively. The antibiofilm properties of the AgNPs and phytoextract were analyzed using the CV assay and MTT assay for determining the reduction of biofilms. Reduction in viability count and revival of the S. aureus ATCC 23235 biofilm cells were analyzed followed by the enfeeblement of the EPS matrix to quantify the reduction in the contents of carbohydrates, proteins and eDNA. The SEM analyses clearly indicated that although the phytoextracts could destroy the biofilm network of S. aureuscells yet the biogenicallysynthesizedAgNPs were more effective in biofilm disruption. Fourier Transformed Infrared Radiations (FT- IR) analyses revealed that the AgNPs could bring about more exopolysaccharide (EPS) destruction in comparison to the phytoextract. The antibiofilm activities of AgNPs made from the phytoextract were found to be much more effective than the non-conjugated phytoextract, indicating the future prospect of using such particles for combatting biofilm-mediated infections caused by S aureus.
- 7 March 2023
- Published by Frontiers Media SA in Frontiers in Chemistry
- Vol. 11, 1118454
Open AccessBiogenic silver nanoparticles (AgNPs) from Tinosporacordifolia leaves: An effective antibiofilm agent against Staphylococcus aureus ATCC 23235
Medicinal plants are long known for their therapeutic applications. Tinospora cordifolia (commonly called gulancha or heart-leaved moonseed plant), a herbaceous creeper widely has been found to have antimicrobial, anti-inflammatory, anti-diabetic, and anti-cancer properties. However, there remains a dearth of reports regarding its antibiofilm activities. In the present study, the anti-biofilm activities of phytoextractof T. cordifolia and the silver nanoparticles made from this phytoextract were tested against the biofilm of S.taphylococcus aureus, one of the major nosocomial infection-producing bacteria taking tetracycline antibiotic as control. Both phytoextract from the leaves of T. cordifolia, and the biogenic AgNPs from the leaf extract of T. cordifolia, were found successful in reducing the biofilm of Staphylococcus aureus. The biogenic AgNPs formed were characterized by UV- Vis spectroscopy, Field emission Scanning Electron Microscopy (FE- SEM), and Dynamic light scattering (DLS) technique. FE- SEM images showed that the AgNPs were of size ranging between 30 and 50 nm and were stable in nature, as depicted by the zeta potential analyzer. MIC values for phytoextract and AgNPs were found to be 180 mg/mL and 150 μg/mL against S. aureusrespectively. The antibiofilm properties of the AgNPs and phytoextract were analyzed using the CV assay and MTT assay for determining the reduction of biofilms. Reduction in viability count and revival of the S. aureus ATCC 23235 biofilm cells were analyzed followed by the enfeeblement of the EPS matrix to quantify the reduction in the contents of carbohydrates, proteins and eDNA. The SEM analyses clearly indicated that although the phytoextracts could destroy the biofilm network of S. aureuscells yet the biogenicallysynthesizedAgNPs were more effective in biofilm disruption. Fourier Transformed Infrared Radiations (FT- IR) analyses revealed that the AgNPs could bring about more exopolysaccharide (EPS) destruction in comparison to the phytoextract. The antibiofilm activities of AgNPs made from the phytoextract were found to be much more effective than the non-conjugated phytoextract, indicating the future prospect of using such particles for combatting biofilm-mediated infections caused by S aureus.
- Open Access
- 9 January 2023
- Published by MDPI AG in Biomedicines
- Vol. 11 (1) , 162
Mechanistic Insights and Potential Therapeutic Approaches in PolyQ Diseases via Autophagy
Polyglutamine diseases are a group of congenital neurodegenerative diseases categorized with genomic abnormalities in the expansion of CAG triplet repeats in coding regions of specific disease-related genes. Protein aggregates are the toxic hallmark for polyQ diseases and initiate neuronal death. Autophagy is a catabolic process that aids in the removal of damaged organelles or toxic protein aggregates, a process required to maintain cellular homeostasis that has the potential to fight against neurodegenerative diseases, but this pathway gets affected under diseased conditions, as there is a direct impact on autophagy-related gene expression. The increase in the accumulation of autophagy vesicles reported in neurodegenerative diseases was due to an increase in autophagy or may have been due to a decrease in autophagy flux. These reports suggested that there is a contribution of autophagy in the pathology of diseases and regulation in the process of autophagy. It was demonstrated in various disease models of polyQ diseases that autophagy upregulation by using modulators can enhance the dissolution of toxic aggregates and delay disease progression. In this review, interaction of the autophagy pathway with polyQ diseases was analyzed, and a therapeutic approach with autophagy inducing drugs was established for disease pathogenesis.
- 9 January 2023
- Published by MDPI AG in Biomedicines
- Vol. 11 (1) , 162
Open AccessMechanistic Insights and Potential Therapeutic Approaches in PolyQ Diseases via Autophagy
Polyglutamine diseases are a group of congenital neurodegenerative diseases categorized with genomic abnormalities in the expansion of CAG triplet repeats in coding regions of specific disease-related genes. Protein aggregates are the toxic hallmark for polyQ diseases and initiate neuronal death. Autophagy is a catabolic process that aids in the removal of damaged organelles or toxic protein aggregates, a process required to maintain cellular homeostasis that has the potential to fight against neurodegenerative diseases, but this pathway gets affected under diseased conditions, as there is a direct impact on autophagy-related gene expression. The increase in the accumulation of autophagy vesicles reported in neurodegenerative diseases was due to an increase in autophagy or may have been due to a decrease in autophagy flux. These reports suggested that there is a contribution of autophagy in the pathology of diseases and regulation in the process of autophagy. It was demonstrated in various disease models of polyQ diseases that autophagy upregulation by using modulators can enhance the dissolution of toxic aggregates and delay disease progression. In this review, interaction of the autophagy pathway with polyQ diseases was analyzed, and a therapeutic approach with autophagy inducing drugs was established for disease pathogenesis.
- Open Access
- 16 December 2022
- Published by Frontiers Media SA in Frontiers in Marine Science
- Vol. 9
Pharmacological potential of Sargassum sp. of west coast of Maharashtra Kunkeshwar, India
A promising plant group that is important in medicine is the seaweed. In this investigation, we have focused on the pharmacological prospects of brown algae (Sargassum sp). Nutraceuticals refer to products that may combine pharmacological and nutrition. We have collected the plant material close to Kunkeeshwar in Sindhudurg, Maharashtra’s western coast. We focused on the Physicochemical Attributes of Sargassum sp., and the study found that the ash value (41 ± 0.67), moisture content (1.33 ± 0.038), alcohol-soluble extractive value (1.5 ± 0.030), moisture content (1.33 ± 0.038), and total cash value (41 ± 0.67) are all stated in (%).The GCMS findings, which demonstrate that a total of 25 chemicals were discovered in the aqueous extract of Sargassum sp., also represent their nutritional profile. All of these substances have chromatograms that can be observed.1-Hexyl-2-nitrocyclohexane is the substance with the second-largest retention duration and relative areas, followed by n-hexadanoic acid. The presence of ocladecanoic acid was later determined. The explanation for how the activity is concentration-dependent is pharmacological activity, particularly antioxidant activity as shown by the DPPH assay.2μg/mL is -1545.4 ± 0.05. as a minimum. and at (32 g/mL is 7.67 ± 0.05) is the highest. The antifungal activity of Candida albicans (12.8 mm) and Aspergillus niger (14.4 mm) both exhibit zone inhibition when tested against two distinct pathogen however, the antibacterial activity of three different bacteria demonstrates that Staphylococcus aureus (12 mm), Bacillus subtilis (10 mm), Proteus mirabilis (12.8 mm), and Escherichia. coli are all zone inhibited (13mm). Brown algae offer the greatest potential for human health nutrition, while pharmacological analysis is helpful for therapeutic application, according to the overall analysis.
- 16 December 2022
- Published by Frontiers Media SA in Frontiers in Marine Science
- Vol. 9
Open AccessPharmacological potential of Sargassum sp. of west coast of Maharashtra Kunkeshwar, India
A promising plant group that is important in medicine is the seaweed. In this investigation, we have focused on the pharmacological prospects of brown algae (Sargassum sp). Nutraceuticals refer to products that may combine pharmacological and nutrition. We have collected the plant material close to Kunkeeshwar in Sindhudurg, Maharashtra’s western coast. We focused on the Physicochemical Attributes of Sargassum sp., and the study found that the ash value (41 ± 0.67), moisture content (1.33 ± 0.038), alcohol-soluble extractive value (1.5 ± 0.030), moisture content (1.33 ± 0.038), and total cash value (41 ± 0.67) are all stated in (%).The GCMS findings, which demonstrate that a total of 25 chemicals were discovered in the aqueous extract of Sargassum sp., also represent their nutritional profile. All of these substances have chromatograms that can be observed.1-Hexyl-2-nitrocyclohexane is the substance with the second-largest retention duration and relative areas, followed by n-hexadanoic acid. The presence of ocladecanoic acid was later determined. The explanation for how the activity is concentration-dependent is pharmacological activity, particularly antioxidant activity as shown by the DPPH assay.2μg/mL is -1545.4 ± 0.05. as a minimum. and at (32 g/mL is 7.67 ± 0.05) is the highest. The antifungal activity of Candida albicans (12.8 mm) and Aspergillus niger (14.4 mm) both exhibit zone inhibition when tested against two distinct pathogen however, the antibacterial activity of three different bacteria demonstrates that Staphylococcus aureus (12 mm), Bacillus subtilis (10 mm), Proteus mirabilis (12.8 mm), and Escherichia. coli are all zone inhibited (13mm). Brown algae offer the greatest potential for human health nutrition, while pharmacological analysis is helpful for therapeutic application, according to the overall analysis.
- Open Access
- 22 November 2022
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 13, 1050453
LC–TOF-MS/MS and GC-MS based phytochemical profiling and evaluation of wound healing activity of Oroxylum Indicum (L.) Kurz (Beka)
Background:Beka (Oroxylum indicum(L.) Kurz) has been used as a culinary herb and natural remedy by the local communities in Malaysia. The leaf ofO. indicumis traditionally used for the treatment of diarrhea, high blood pressure, and improving digestive health.Objectives:The present study was conducted to evaluate the phytochemical constituents and wound healing properties (in vitroandin vivomodels) of aqueous and ethanol extracts ofO. indicumleaves.Methods:The total phenolic (TPC) and total flavonoid (TFC) contents in the plant extracts were determined by the spectrophotometric methods. Further, the extract was characterized by Liquid Chromatography Time-of-Flight Mass Spectrometry (LC-TOF-MS/MS) and Gas Chromatography-Mass Spectrometry (GC-MS). The wound healing activity was assessed using thein vitroscratch wound-healing assay andin vivoexcisional wound model.Results:The results show the ethanol leaves extract had the higher TPC (164 mg GAE/g) when compared with the aqueous leaves extract (30 mg gallic acid equivalents/g). The ethanol leaves extract was also found to have higher TFC (101 mg Catechin equivalents/g) than the aqueous leaves extract (76 mg Catechin equivalents/g). The ethanol leaves extract was then used for further chemical analysis. The LC–TOF-MS/MS analysis showed that the leaves extracts ofO. indicumcontains many important compounds such as Orientin, Chrysin, Pinoquercetin, Cupressuflavone, Puerarin xyloside, Forsythiaside and Paederoside. In GC-MS analysis, 19 compounds were identified in ethanolic leaves extract. The wound healing studies shows thatO. indicumhas promising wound healing activity by increasing the rate of wound contraction significantly (p< 0.05).Conclusion:In conclusion, the present study showed thatO. indicumleaf contains important phytochemicals and the wound healing potential of theO. indicumextract may probably be as a result of the presence of various phytoconstituents.
- 22 November 2022
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 13, 1050453
Open AccessLC–TOF-MS/MS and GC-MS based phytochemical profiling and evaluation of wound healing activity of Oroxylum Indicum (L.) Kurz (Beka)
Background:Beka (Oroxylum indicum(L.) Kurz) has been used as a culinary herb and natural remedy by the local communities in Malaysia. The leaf ofO. indicumis traditionally used for the treatment of diarrhea, high blood pressure, and improving digestive health.Objectives:The present study was conducted to evaluate the phytochemical constituents and wound healing properties (in vitroandin vivomodels) of aqueous and ethanol extracts ofO. indicumleaves.Methods:The total phenolic (TPC) and total flavonoid (TFC) contents in the plant extracts were determined by the spectrophotometric methods. Further, the extract was characterized by Liquid Chromatography Time-of-Flight Mass Spectrometry (LC-TOF-MS/MS) and Gas Chromatography-Mass Spectrometry (GC-MS). The wound healing activity was assessed using thein vitroscratch wound-healing assay andin vivoexcisional wound model.Results:The results show the ethanol leaves extract had the higher TPC (164 mg GAE/g) when compared with the aqueous leaves extract (30 mg gallic acid equivalents/g). The ethanol leaves extract was also found to have higher TFC (101 mg Catechin equivalents/g) than the aqueous leaves extract (76 mg Catechin equivalents/g). The ethanol leaves extract was then used for further chemical analysis. The LC–TOF-MS/MS analysis showed that the leaves extracts ofO. indicumcontains many important compounds such as Orientin, Chrysin, Pinoquercetin, Cupressuflavone, Puerarin xyloside, Forsythiaside and Paederoside. In GC-MS analysis, 19 compounds were identified in ethanolic leaves extract. The wound healing studies shows thatO. indicumhas promising wound healing activity by increasing the rate of wound contraction significantly (p< 0.05).Conclusion:In conclusion, the present study showed thatO. indicumleaf contains important phytochemicals and the wound healing potential of theO. indicumextract may probably be as a result of the presence of various phytoconstituents.
- Open Access
- 3 October 2022
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 13, 939390
Anti-biofilm efficacy of green-synthesized ZnO nanoparticles on oral biofilm: In vitro and in silico study
The development of biofilm on the biotic and abiotic surfaces is the greatest challenge for health care sectors. At present times, oral infection is a common concern among people with an unhealthy lifestyle and most of these biofilms-associated infections are resistant to antibiotics. This has increased a search for the development of alternate therapeutics for eradicating biofilm-associated infection. Nanobiotechnology being an effective way to combat such oral infections may encourage the use of herbal compounds, such as bio-reducing and capping agents. Green-synthesis of ZnO nanoparticles (ZnO NP) by the use of the floral extract of Clitoria ternatea, a traditionally used medicinal plant, showed stability for a longer period of time. The NPs as depicted by the TEM image with a size of 10 nm showed excitation spectra at 360 nm and were found to remain stable for a considerable period of time. It was observed that the NPs were effective in the eradication of the oral biofilm formed by the major tooth attacking bacterial strains namely Porphyromonsas gingivalis and Alcaligenes faecalis, by bringing a considerable reduction in the extracellular polymeric substances (EPS). It was observed that the viability of the Porphyromonsas gingivalis and Alcaligenes faecalis was reduced by NP treatment to 87.89 ± 0.25% in comparison to that of amoxicillin. The results went in agreement with the findings of modeling performed by the use of response surface methodology (RSM) and artificial neural network (ANN). The microscopic studies and FT-IR analysis revealed that there was a considerable reduction in the biofilm after NP treatment. The in silico studies further confirmed that the ZnO NPs showed considerable interactions with the biofilm-forming proteins. Hence, this study showed that ZnO NPs derived from Clitoria ternatea can be used as an effective alternative therapeutic for the treatment of biofilm associated oral infection.
- 3 October 2022
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 13, 939390
Open AccessAnti-biofilm efficacy of green-synthesized ZnO nanoparticles on oral biofilm: In vitro and in silico study
The development of biofilm on the biotic and abiotic surfaces is the greatest challenge for health care sectors. At present times, oral infection is a common concern among people with an unhealthy lifestyle and most of these biofilms-associated infections are resistant to antibiotics. This has increased a search for the development of alternate therapeutics for eradicating biofilm-associated infection. Nanobiotechnology being an effective way to combat such oral infections may encourage the use of herbal compounds, such as bio-reducing and capping agents. Green-synthesis of ZnO nanoparticles (ZnO NP) by the use of the floral extract of Clitoria ternatea, a traditionally used medicinal plant, showed stability for a longer period of time. The NPs as depicted by the TEM image with a size of 10 nm showed excitation spectra at 360 nm and were found to remain stable for a considerable period of time. It was observed that the NPs were effective in the eradication of the oral biofilm formed by the major tooth attacking bacterial strains namely Porphyromonsas gingivalis and Alcaligenes faecalis, by bringing a considerable reduction in the extracellular polymeric substances (EPS). It was observed that the viability of the Porphyromonsas gingivalis and Alcaligenes faecalis was reduced by NP treatment to 87.89 ± 0.25% in comparison to that of amoxicillin. The results went in agreement with the findings of modeling performed by the use of response surface methodology (RSM) and artificial neural network (ANN). The microscopic studies and FT-IR analysis revealed that there was a considerable reduction in the biofilm after NP treatment. The in silico studies further confirmed that the ZnO NPs showed considerable interactions with the biofilm-forming proteins. Hence, this study showed that ZnO NPs derived from Clitoria ternatea can be used as an effective alternative therapeutic for the treatment of biofilm associated oral infection.
- Open Access
- 9 August 2022
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 13, 964848
Precision targeting of food biofilm-forming genes by microbial scissors: CRISPR-Cas as an effective modulator
The abrupt emergence of antimicrobial resistant (AMR) bacterial strains has been recognized as one of the biggest public health threats affecting the human race and food processing industries. One of the causes for the emergence of AMR is the ability of the microorganisms to form biofilm as a defense strategy that restricts the penetration of antimicrobial agents into bacterial cells. About 80% of human diseases are caused by biofilm-associated sessile microbes. Bacterial biofilm formation involves a cascade of genes that are regulated via the mechanism of quorum sensing (QS) and signaling pathways that control the production of the extracellular polymeric matrix (EPS), responsible for the three-dimensional architecture of the biofilm. Another defense strategy utilized commonly by various bacteria includes clustered regularly interspaced short palindromic repeats interference (CRISPRi) system that prevents the bacterial cell from viral invasion. Since multigenic signaling pathways and controlling systems are involved in each and every step of biofilm formation, the CRISPRi system can be adopted as an effective strategy to target the genomic system involved in biofilm formation. Overall, this technology enables site-specific integration of genes into the host enabling the development of paratransgenic control strategies to interfere with pathogenic bacterial strains. CRISPR-RNA-guided Cas9 endonuclease, being a promising genome editing tool, can be effectively programmed to re-sensitize the bacteria by targeting AMR-encoding plasmid genes involved in biofilm formation and virulence to revert bacterial resistance to antibiotics. CRISPRi-facilitated silencing of genes encoding regulatory proteins associated with biofilm production is considered by researchers as a dependable approach for editing gene networks in various biofilm-forming bacteria either by inactivating biofilm-forming genes or by integrating genes corresponding to antibiotic resistance or fluorescent markers into the host genome for better analysis of its functions both in vitro and in vivo or by editing genes to stop the secretion of toxins as harmful metabolites in food industries, thereby upgrading the human health status.
- 9 August 2022
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 13, 964848
Open AccessPrecision targeting of food biofilm-forming genes by microbial scissors: CRISPR-Cas as an effective modulator
The abrupt emergence of antimicrobial resistant (AMR) bacterial strains has been recognized as one of the biggest public health threats affecting the human race and food processing industries. One of the causes for the emergence of AMR is the ability of the microorganisms to form biofilm as a defense strategy that restricts the penetration of antimicrobial agents into bacterial cells. About 80% of human diseases are caused by biofilm-associated sessile microbes. Bacterial biofilm formation involves a cascade of genes that are regulated via the mechanism of quorum sensing (QS) and signaling pathways that control the production of the extracellular polymeric matrix (EPS), responsible for the three-dimensional architecture of the biofilm. Another defense strategy utilized commonly by various bacteria includes clustered regularly interspaced short palindromic repeats interference (CRISPRi) system that prevents the bacterial cell from viral invasion. Since multigenic signaling pathways and controlling systems are involved in each and every step of biofilm formation, the CRISPRi system can be adopted as an effective strategy to target the genomic system involved in biofilm formation. Overall, this technology enables site-specific integration of genes into the host enabling the development of paratransgenic control strategies to interfere with pathogenic bacterial strains. CRISPR-RNA-guided Cas9 endonuclease, being a promising genome editing tool, can be effectively programmed to re-sensitize the bacteria by targeting AMR-encoding plasmid genes involved in biofilm formation and virulence to revert bacterial resistance to antibiotics. CRISPRi-facilitated silencing of genes encoding regulatory proteins associated with biofilm production is considered by researchers as a dependable approach for editing gene networks in various biofilm-forming bacteria either by inactivating biofilm-forming genes or by integrating genes corresponding to antibiotic resistance or fluorescent markers into the host genome for better analysis of its functions both in vitro and in vivo or by editing genes to stop the secretion of toxins as harmful metabolites in food industries, thereby upgrading the human health status.